Strategic Capital and Global Partners for Commercial Neuromodulation Platform
Commercial-stage wellness neurotechnology with thousands of users, recurring provider revenue, and a next-generation neuromodulation pipeline seeks strategic investors, manufacturers, distributors, and institutional partners to accelerate global scale.
Free for connectors. Already have an account?
I Have
- Technology or Product Available for Licensing or Distribution
- Investment Opportunity
- Partnership or Strategic Collaboration Opportunity
The company has commercially deployed a low-risk general wellness neuromodulation platform designed to support calm, sleep quality, and overall well-being. The platform has served well over 5,000 users and is supported by real-world evidence, pilot studies, and active research programs. Revenue models include direct sales, professional and provider placements, equipment leasing, and recurring software and service revenue. Near-term production plans are established, including an initial manufacturing opportunity of approximately 500–1,000 units and the potential for materially larger follow-on volumes. The company is also developing a next-generation, noninvasive transcranial electrical stimulation platform with potential indications for Parkinson’s disease, Alzheimer’s disease, and other dementias, with current efforts focused on research, clinical validation, and future commercialization. The company is offering a $10 million Series A and is particularly interested in strategic investors that can also provide manufacturing, distribution, institutional access, or international commercialization capabilities. Confidential technical, clinical, intellectual-property, financial, and manufacturing materials are available following mutual qualification and an NDA.
Looking For
- Capital or Investment
- Market Access or Distribution Channel
- Service Provider in a Specific Geography or Niche
- Strategic Business Relationship
- Company for Partnership or Joint Venture
Priorities include: 1) Strategic investors, family offices, healthcare investors, and medtech or neurotechnology funds able to participate in the company’s current financing. 2) Established distributors, provider networks, wellness platforms, senior-living organizations, health-system innovation groups, and other institutional commercialization partners. 3) Qualified contract manufacturers capable of supporting an initial 500–1,000-unit production run and scaling to substantially larger volumes. 4) Regional partners with regulatory, clinical-development, distribution, or market-entry capabilities in North America, Europe, Asia, or the Middle East. The strongest fit is a partner able to combine capital with manufacturing, distribution, institutional adoption, or geographic market access.
You Get
- Licensing Rights or Access
- Royalties or Usage-Based Payments
- Strategic Partnership Opportunity
Compensation is open and will be structured based on the nature and value of the introduction, the resulting transaction, the connector’s role, and all applicable legal and regulatory requirements. All terms must be agreed in writing in advance and structured in full compliance with applicable securities, broker-dealer, referral-fee, licensing, and other requirements. Compensation will depend on a qualified introduction that results in a meaningful transaction or ongoing relationship and is not earned solely by providing a name or contact.
Attachments
LockedFiles attached to this deal (pitch decks, financials, term sheets) are revealed after the poster accepts your connection request.
Company Details
Company details locked
Request a connection above. Once the poster accepts, company name, email, phone, and website appear here.